Cynthia Seidel‐Dugan
Cynthia Seidel‐Dugan publishes mostly in Oncology, Molecular Biology and Immunology, on topics such as Monoclonal and Polyclonal Antibodies Research, CAR-T cell therapy research and Cancer-related Molecular Pathways.
- World rank
- #1,859,573 of 7,710,434 ranked researchers
- Rank in United States
- #569,439 of 1,627,098
- Works
- 102
- Citations
- 1.7k
- Citations per work
- 16.9
What does Cynthia Seidel‐Dugan research?
Cynthia Seidel‐Dugan's work is mostly in Medicine (40%), Biochemistry, Genetics and Molecular Biology (28%), Immunology and Microbiology (13%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Life Sciences4241.1%
- Health Sciences4140.2%
- Medicine4140.2%
- Everything else1918.7%
- 1Oncology24% of their works
- 2Molecular Biology22% of their works
- 3Immunology13% of their works
- 4Radiology, Nuclear Medicine and Imaging10% of their works
- 5Cancer Research6% of their works
- 6Epidemiology6% of their works
Research topics
Which keywords describe Cynthia Seidel‐Dugan's research?
The keywords of their largest research topics: Cancer Therapy, Immunotherapy, Tumor Regression, Apoptosis, Fc Receptors, Therapeutic Antibodies, CAR T Cells and Chimeric Antigen Receptor.
- Tumor Targeting
- Cantharidin
- Ras Signaling
- PD-1 and PD-L1
- Herpesviruses
- p53
- Chimeric Antigen Receptor
- Therapeutic Antibodies
- Apoptosis
- Immunotherapy
- Cancer Therapy
- Tumor Regression
- Fc Receptors
- CAR T Cells
- Cell Cycle
- Herpes Zoster
- Immune Checkpoint Blockade
- Protein Kinases
- Bacterial Therapy
- Protein Phosphatase Inhibitors
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 20 words, with their numbers
- Cancer Therapy132 topics
- Immunotherapy132 topics
- Tumor Regression132 topics
- Apoptosis122 topics
- Fc Receptors111 topic
- Therapeutic Antibodies111 topic
- CAR T Cells91 topic
- Chimeric Antigen Receptor91 topic
- Cell Cycle81 topic
- p5381 topic
- Herpes Zoster51 topic
- Herpesviruses51 topic
- Immune Checkpoint Blockade51 topic
- PD-1 and PD-L151 topic
- Protein Kinases51 topic
- Ras Signaling51 topic
- Bacterial Therapy41 topic
- Cantharidin41 topic
- Protein Phosphatase Inhibitors41 topic
- Tumor Targeting41 topic
Where does Cynthia Seidel‐Dugan work?
Cynthia Seidel‐Dugan's main affiliation in the publication record is Merck & Co., Inc., Rahway, NJ, USA (United States), United States.
How many publications and citations does Cynthia Seidel‐Dugan have?
OpenAlex counts 102 works and 1,721 citations for Cynthia Seidel‐Dugan, an h-index of 19, ranking #1,859,573 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Cynthia Seidel‐Dugan. Posts are plain text and can be reported.